Skip to main content
. 2020 Feb 21;11(1):222–237. doi: 10.1080/21505594.2020.1731126

Figure 5.

Figure 5.

Activity inhibition and degradation of PPOs by MrM35-4. Deactivation of rPPO1 (a) and rPPO2 (b) activity. The reaction buffer (50 μl) contains 50 μg of rPPO1 and 1 μg of either MrM35-4 or α-chymotrypsin (α-Chy) and the tubes were photographed after reaction for 15 min. Comparative degradation of rPPO1 (c) and rPPO2 (d) by MrM35-4 and α-Chy for different times. Arrowed bands show the differences between two enzyme treatments.